Parkwalk Advisors
2 rounds tracked since 25 September 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $15M
Sectors
Countries
Rounds
- Scripta TherapeuticsDrug discovery targeting transcription factor activity in neurodegeneration $12MSeed · 13 Nov
- TrismikAdaptive psychometric testing platform for evaluating large language models $3MPre-Seed · 25 Sept
No round matches these filters.